Company
Role
Would you like to be part of transforming healthcare? Qbtech is the global market leader in professional ADHD tests, providing CE-marked and FDA-cleared solutions used to support the assessment and treatment evaluation of ADHD for people aged 6–60 in 15 countries. Qbtech’s ambition is to transform healthcare by delivering a comprehensive system of objective tests, products, and services that support clinical and financial decision-makers in improving outcomes and helping patients better understand their symptoms and treatment.
Qbtech is present in 15 countries with offices in Stockholm, London, and Houston. Over the coming years, the company will continue to invest in new products, technologies, and people to strengthen its offering and build an ecosystem of solutions for providers, clinicians, and patients.
As Chief Product Officer, you are responsible for setting Qbtech’s product direction and ensuring that product strategy, technology choices, development, and business priorities are aligned — while safeguarding clinical validity, regulatory integrity, and long-term trust in how Qbtech’s products are used in real clinical decision-making.
In this role, you will:
This role is part of the executive leadership team, reports to the CEO, and operates in an international and regulated environment spanning Europe, the United States, New Zealand, and Australia.
We are looking for someone who:
At Qbtech, you will work on products that improve ADHD care while helping shape the direction of a company focused on transforming healthcare. You will operate in an international setting together with experienced colleagues and domain experts across product, technology, medical, and commercial functions.
You will influence the development of both established and new products and services used globally, with the opportunity to shape how the product ecosystem evolves as the company continues to grow. Qbtech also supports ongoing learning through education and certifications relevant to the technologies used within the company.
Qbtech (Quantitative Behavior Technology) was founded in Sweden in 2002 with a vision to transform healthcare through objective tests, products, and services that support better clinical and financial decision-making. Qbtech currently serves 15 countries through offices in Sweden, the UK, and the US.
As the market leader in objective ADHD management, Qbtech collaborates with academic and clinical researchers, technology partners, and patient associations to develop well-documented products that support the assessment and monitoring of ADHD across different healthcare systems.